Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts.
Although it is generally accepted that destruction and remodeling of temporal bone associated with middle ear cholesteatoma is mainly caused by the action of osteoclasts, it has been shown that neutral collagenases also play a role in predigesting the osteoid layer and exposing the mineralized bone to osteoclastic activity. Here we show that gelatinase B (matrix metalloproteinase-9) is over-expressed in cholesteatoma compared to external ear canal skin (EACS). Expression of MMP-9 in cholesteatoma mainly occurs in suprabasal layers, and more rarely in basal layers of cholesteatoma epithelium, as well as in inflammatory cells of the perimatrix. We further analyzed the influence of cholesteatoma debris, cholesteatoma granulation tissue, and cholesteatoma components such as keratin, cholesterol and bacterial endotoxin on the expression of MMPs in EACS keratinocytes. We show that cholesteatoma debris and granulation tissue extract both induced the secretion of MMP-9 by EACS keratinocytes, while keratin. bacterial lipopolysaccharide (LPS) or cholesterol did not show any effect. We further performed co-incubation and immunoprecipitation experiments using neutralizing interleukin-1alpha, EGF, TGF-beta, TGF-alpha, interleukin-6 and TNF-alpha antibodies. Inhibition of MMP-9 up-regulation by debris or granulation tissue extract could be revealed with diverse cytokine antibodies. The results are discussed with regard to previously published studies.
Schmidt
M
M
University of Wuerzburg, Department of Otorhinolaryngology, Germany. marianne.schmidt@mail.uni-wuerzburg.de
Grünsfelder
P
P
Hoppe
F
F
D000906:Antibodies / Q000276:immunology; D018929:Cell Culture Techniques; D018424:Cholesteatoma, Middle Ear / Q000201:enzymology* / Q000276:immunology; D004790:Enzyme Induction; D004815:Epidermal Growth Factor / Q000276:immunology; D006097:Granulation Tissue / Q000201:enzymology / Q000276:immunology; D006801:Humans; D015850:Interleukin-6 / Q000276:immunology; D015603:Keratinocytes / Q000201:enzymology* / Q000276:immunology; D020782:Matrix Metalloproteinases / Q000096:biosynthesis*; D011233:Precipitin Tests; D016211:Transforming Growth Factor alpha / Q000276:immunology; D016212:Transforming Growth Factor beta / Q000276:immunology
D000906:Antibodies; D015850:Interleukin-6; D016211:Transforming Growth Factor alpha; D016212:Transforming Growth Factor beta; D004815:Epidermal Growth Factor; D020782:Matrix Metalloproteinases